EGFR and lung adenocarcinoma: Epidermal growth factor receptor (EGFR) mutations are major drivers of oncogenic alterations that account for an important molecular subtype of lung adenocarcinoma, comprising 40–60% of cases in the South-East Asian population and 10–20% among Caucasian patients1.